Sangui BioTech International Inc.: Information Letter for Shareholders and Interested Parties...

Business Editors

SANTA ANA, Calif.--(BUSINESS WIRE)--May 22, 2001

Sangui BioTech International Inc., (NASDAQ OTC BB: SGBI; WKN 906 757; SBH.GR (Bloomberg), SGBI.H (Reuters)) announced that a new edition of its information letter "Sangui News" for shareholders and interested

The newsletter may be downloaded from the company's Web site www.sangui.de either in English or German. Printed copies of the letter may be obtained by request via fax or email.

This news release includes statements, other than historical fact, that may be deemed forward-looking. These statements may be accompanied by words such as "believe," "estimate," "project," "expect," "anticipate," or "predict" that conveys the uncertainty of future events or outcomes. These statements are based on assumptions that the company believes are reasonable; however, many factors could cause the company's actual results in the future to differ materially from the forward-looking statements made herein and in any other documents or oral presentations made by, or on behalf of, the company. Important factors which could cause actual results to differ materially from those in forward-looking statements include, among others, the ability to obtain additional financing, which is not assured; rapid technological developments and changes; problems in developments of the company's products; price and product competition by competitors; general economic conditions; and factors discussed in the company's SEC filings.